SIC
ANGO icon

SJS Investment Consulting’s AngioDynamics ANGO Stock Holding History

SJS Investment Consulting’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599 Buy
46
+29
+171% +$330 ﹤0.01% 2205
2026
Q1 		$194 Sell
17
-16
-48% -$173 ﹤0.01% 1988
2025
Q4 		$424 Buy
+33
New +$407 ﹤0.01% 1589

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

SJS Investment Consulting's ANGO Position: Q2 2026 in Review

SJS Investment Consulting increased its AngioDynamics (ANGO) stake by 171% in Q2 2026, buying an estimated $330 and bringing the position to 46 shares worth $599. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

SJS Investment Consulting first reported a position in ANGO in Q4 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • SJS Investment Consulting held 46 shares of AngioDynamics worth $599 as of Q2 2026.
  • SJS Investment Consulting bought 29 AngioDynamics shares in Q2 2026, an estimated $330.
  • AngioDynamics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2205 holding.
  • SJS Investment Consulting first reported a position in AngioDynamics in Q4 2025 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.